FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048414944> ?p ?o ?g. }

• W3048414944 endingPage "102641" @default.
• W3048414944 startingPage "102641" @default.
• W3048414944 abstract "Patients with antiphospholipid syndrome (APS) present with clinical features of recurrent thrombosis and pregnancy morbidity and persistently test positive for the presence of antiphospholipid antibodies (aPL). At least one clinical (vascular thrombosis or pregnancy morbidity) and one lab-based (positive test result for lupus anticoagulant, anticardiolipin antibodies and/or anti-β2-glycoprotein 1 antibodies) criterion have to be met for a patient to be classified as having APS. Nevertheless, the clinical variety of APS encompasses additional signs and symptoms, potentially affecting any organ, that cannot be explained exclusively by a prothrombotic state. Those manifestations, also known as extra-criteria manifestations, include haematologic (thrombocytopenia and haemolytic anaemia), neurologic (chorea, myelitis and migraine) manifestations as well as the presence of livedo reticularis, nephropathy and valvular heart disease. The growing body of evidence describing the clinical aspect of the syndrome has been paralleled over the years by emerging research interest focusing on the development of novel biomarkers that might improve the diagnostic accuracy for APS when compared to the current aPL tests. This review will focus on the clinical utility of extra-criteria aPL specificities. Besides, the promising role of a new technology using particle based multi-analyte testing that supports aPL panel algorithm testing will be discussed. Diagnostic approaches to difficult cases, including real-world case studies investigating the diagnostic added value of extra criteria aPL, particularly anti-phosphatidylserine/prothrombin, will also be examined." @default.
• W3048414944 created "2020-08-18" @default.
• W3048414944 creator A5000160988 @default.
• W3048414944 creator A5012705049 @default.
• W3048414944 creator A5014323438 @default.
• W3048414944 creator A5017039749 @default.
• W3048414944 creator A5018929604 @default.
• W3048414944 creator A5022973825 @default.
• W3048414944 creator A5030770013 @default.
• W3048414944 creator A5048345840 @default.
• W3048414944 creator A5054660181 @default.
• W3048414944 creator A5065754261 @default.
• W3048414944 creator A5073274706 @default.
• W3048414944 creator A5084623903 @default.
• W3048414944 creator A5086035399 @default.
• W3048414944 creator A5090996568 @default.
• W3048414944 date "2020-10-01" @default.
• W3048414944 modified "2023-10-16" @default.
• W3048414944 title "Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome" @default.
• W3048414944 cites W1820213619 @default.
• W3048414944 cites W2054330426 @default.
• W3048414944 cites W2069797332 @default.
• W3048414944 cites W2086324194 @default.
• W3048414944 cites W2098261358 @default.
• W3048414944 cites W2127565509 @default.
• W3048414944 cites W2252943105 @default.
• W3048414944 cites W2741174708 @default.
• W3048414944 cites W2805670339 @default.
• W3048414944 cites W2897820616 @default.
• W3048414944 cites W2898011957 @default.
• W3048414944 cites W2910916767 @default.
• W3048414944 cites W2915059950 @default.
• W3048414944 cites W2921731994 @default.
• W3048414944 cites W2925891945 @default.
• W3048414944 cites W2929968164 @default.
• W3048414944 cites W2962606696 @default.
• W3048414944 cites W2972980497 @default.
• W3048414944 cites W2981008954 @default.
• W3048414944 cites W3007806825 @default.
• W3048414944 cites W3011535590 @default.
• W3048414944 cites W4296981399 @default.
• W3048414944 doi "https://doi.org/10.1016/j.autrev.2020.102641" @default.
• W3048414944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32801044" @default.
• W3048414944 hasPublicationYear "2020" @default.
• W3048414944 type Work @default.
• W3048414944 sameAs 3048414944 @default.
• W3048414944 citedByCount "11" @default.
• W3048414944 countsByYear W30484149442020 @default.
• W3048414944 countsByYear W30484149442021 @default.
• W3048414944 countsByYear W30484149442022 @default.
• W3048414944 countsByYear W30484149442023 @default.
• W3048414944 crossrefType "journal-article" @default.
• W3048414944 hasAuthorship W3048414944A5000160988 @default.
• W3048414944 hasAuthorship W3048414944A5012705049 @default.
• W3048414944 hasAuthorship W3048414944A5014323438 @default.
• W3048414944 hasAuthorship W3048414944A5017039749 @default.
• W3048414944 hasAuthorship W3048414944A5018929604 @default.
• W3048414944 hasAuthorship W3048414944A5022973825 @default.
• W3048414944 hasAuthorship W3048414944A5030770013 @default.
• W3048414944 hasAuthorship W3048414944A5048345840 @default.
• W3048414944 hasAuthorship W3048414944A5054660181 @default.
• W3048414944 hasAuthorship W3048414944A5065754261 @default.
• W3048414944 hasAuthorship W3048414944A5073274706 @default.
• W3048414944 hasAuthorship W3048414944A5084623903 @default.
• W3048414944 hasAuthorship W3048414944A5086035399 @default.
• W3048414944 hasAuthorship W3048414944A5090996568 @default.
• W3048414944 hasBestOaLocation W30484149442 @default.
• W3048414944 hasConcept C126322002 @default.
• W3048414944 hasConcept C159654299 @default.
• W3048414944 hasConcept C163764329 @default.
• W3048414944 hasConcept C177713679 @default.
• W3048414944 hasConcept C203014093 @default.
• W3048414944 hasConcept C2776874634 @default.
• W3048414944 hasConcept C2778868616 @default.
• W3048414944 hasConcept C2779134260 @default.
• W3048414944 hasConcept C2779974317 @default.
• W3048414944 hasConcept C2780022809 @default.
• W3048414944 hasConcept C2780868729 @default.
• W3048414944 hasConcept C71924100 @default.
• W3048414944 hasConceptScore W3048414944C126322002 @default.
• W3048414944 hasConceptScore W3048414944C159654299 @default.
• W3048414944 hasConceptScore W3048414944C163764329 @default.
• W3048414944 hasConceptScore W3048414944C177713679 @default.
• W3048414944 hasConceptScore W3048414944C203014093 @default.
• W3048414944 hasConceptScore W3048414944C2776874634 @default.
• W3048414944 hasConceptScore W3048414944C2778868616 @default.
• W3048414944 hasConceptScore W3048414944C2779134260 @default.
• W3048414944 hasConceptScore W3048414944C2779974317 @default.
• W3048414944 hasConceptScore W3048414944C2780022809 @default.
• W3048414944 hasConceptScore W3048414944C2780868729 @default.
• W3048414944 hasConceptScore W3048414944C71924100 @default.
• W3048414944 hasIssue "10" @default.
• W3048414944 hasLocation W30484149441 @default.
• W3048414944 hasLocation W30484149442 @default.
• W3048414944 hasOpenAccess W3048414944 @default.
• W3048414944 hasPrimaryLocation W30484149441 @default.
• W3048414944 hasRelatedWork W1967516704 @default.
• W3048414944 hasRelatedWork W2051478454 @default.

• next